The office building shows the signature work of renowned Uruguayan architect Carlos Ott, embodying innovation and modernity. Its innovative architectural design focuses on workers' well-being, integrating state-of-the-art technology for efficient and environmentally friendly air conditioning. Thus, it offers a healthy working environment and complies with rigorous international standards, ensuring the excellence in safety and quality for which we are known.
Hormone products plant
Advanced technologies
for hormone
products.
Urufarma holds a remarkable position in Latin America thanks to its state-of-the-art industrial plant manufacturing hormone products. Thanks to internationally recognized certifications and a steadfast commitment to sustainability, Urufarma has become a benchmark in the regional pharmaceutical industry. With an annual production capacity of 40 million units and a strong focus on technological innovation, Urufarma is positioned as a pioneering force in the Latin American markets.
Hemato-oncological products plant
High containment
and operational flexibility.
The use of state-of-the-art technology makes the new haemato-oncological products plant the only facility of its kind in the country. Equipped with high-containment systems and operational flexibility, it ensures both safety and efficiency in the manufacturing of complex products. With vast experience in potent drug management, we renew our commitment to excellence and innovation to contribute to a healthier society.
Non-segregated products plant
Efficiency,
quality, and safety.
We have a rigorous manufacturing process in place, where we manufacture a wide range of pharmaceutical products, including analgesics, antibiotics, and antipyretics. This plant stands out for its efficiency and flexibility, making it possible to meet the market's diverse needs with high quality and safety standards.
Quality at the highest level
Quality
Control labs.
Urufarma has state-of-the-art physical-chemical and microbiology testing labs to meet the most rigorous international standards.
We have a strict validation process for all supplies, from raw materials to active ingredients and excipients. We control their suitability for the manufacturing processes and have thorough quality assurance processes in place for end products to ensure their safety and efficacy.
In addition, Urufarma's quality assurance lab is GLP (Good Laboratory Practices) certified, which reflects our commitment to quality, integrity, and transparency at every stage of the manufacturing process.
The Quality Management System frequently welcomes auditors from all over the world to assess and validate processes based on the requirements of different countries. In addition, the company carries out internal audits to check, validate, and update the best practices across all processes. These practices include ongoing staff training, comprehensive documentation of all processes, and ongoing monitoring for continuous updates.
Enviromental conservation and energy efficiency:
A wide-ranging commitment.
Urufarma is thoroughly committed to sustainability across all aspects of our operation. We have in place emission control and water treatment systems, as well as energy-efficient processes, to integrate practices that minimize environmental impact. The effluent treatment plant uses advanced technologies for wastewater safety and quality. In addition, we have implemented an Energy Efficiency Management System in collaboration with MCT ESCO to optimize energy use and reduce our environmental footprint.